期刊文献+

铜绿假单胞菌产AmpC酶和ESBLs的检测和耐药性分析 被引量:3

The Detection of AmpC enzyme and extended-spectrumβ-lactamase and analysis of drug resistance in Pseudomonas aeruginosa
下载PDF
导出
摘要 目的研究AmpC酶和ESBLs在临床分离铜绿假单胞菌中的分布及其对耐药性的影响。方法纸片扩散法测定19种抗生素的耐药性,三维试验检测高产AmpC酶和超广谱β-内酰胺酶(ESBLs)。结果92株铜绿假单胞菌中,单纯高产AmpC酶者,单纯产ESBLs者,高产AmpC酶并产ESBLs者分别为17.4%、8.7%、10.7%。产酶菌株仅对美洛培南亚胺培南敏感,对大多数抗生素耐药。非产酶菌株对头孢西丁、氨苄西林/舒巴坦、头孢噻肟、头孢唑林高度耐药,对大多数抗生素敏感。结论产ESBLs和高产AmpC酶的铜绿假单胞菌在临床分离菌株中阳性率较高,产酶菌株对大多数抗生素的耐药性明显高于非产酶菌株。 Objective To investigate the prevalence of AmpC β-lactamases and extended-spectrumβ-lactamases in Pseudomonas aeruginosa srain and its impact on antibiotic susceptibility. Methods The susceptibility study was tested using the disc diffusion method according to recommendation of the Clinical and Laboratory Standards Institute. A modified three-dimensional extract method was used to determine the phenotype of Pscudomonas aeruginosa harboring AmpC β-lactamases and extended-spectmnβ-lactamases. Results Among 106 strains of Pseudomonas aeruginosa, 17.4% produced only AmpC β-lactamases 8.7 % produced only ESBLs 10. 7% produced both high-level AmpC β-lactamases and ESBLs. Lactamase producing strains were only susceptible to meropenem, imipenem.non-lactamase producing strains were susceptible to most antibiotics. Conclusion The incidence of lactamases in Pseudomonas aeruginosa was rather high, lactamase producing strains show more resistance to most antibiotics than non-lactamase producing strains.
出处 《中国实验诊断学》 2007年第7期946-948,共3页 Chinese Journal of Laboratory Diagnosis
关键词 铜绿假单胞菌 三维试验 超广谱β-内酰胺酶(ESBLs) AMPC酶 pseudomonas aeruginosa three-dimensional test extended- spectmmβ-lactamas AmpC enzyme
  • 相关文献

参考文献8

  • 1Juan C,Macia MD,GutierrezO,et al.Molecular mechanism of β-lactam resistance mediated by AmpC hypetprouction in pseudomonas aeruginosa clinical strains[J].Antimicrobial Agents and Chemotherapy,2005,49(11):4733.
  • 2Clinical and Laboratory Standards Institute.Perfor-mance Standards for antimicrobial susceptibility testing;Fifteenth information supplement.CLSI/NCCLB document M100-S15[J].Clinical and Laboratory Standards Institute,Wayne,Pennsylvania,2005,25(1):1.
  • 3Shahid M,Malik A,Agrawal M,et al.Phenotypic detection of extendedspectrum and ApmC beta-lactamase by a new spot-inoculation method and modified three-dimensional extract test comparison with the conventional three-dimensional extract test[J].Jantimicrob Chemother,2004,54(3):684.
  • 4Akasaka T,Tanaka M,Yamaguchi A,et al.Type Ⅱ topoisomerase mutations in fluoroquinolone-resistance clinical strains of pseudomonas aeruginosa isolation in 1998 and 1999:role of target enzyme in mechanism of fluoroquinolone resistance[J].J antimicrob Agents Chemother,2001,45(8):2263.
  • 5Weldhagen GF,Poirel L,Nordmann P,et al.Amblerclass A extnded-spectrum β-lactamase Pseudomona-Saeruginosa Novel developments and clinical impa-Ct[J].Antimi Crobiol Agents and Chemotherapy,2003,47(8):2385.
  • 6Juan C,Macia MD,Gutierrez O,et al.Molecular mechanisms of beta-lactam resistance mediated by AmpC hyperproduction in Pseudomonas aeruginosa Clinical Strains[J].Antimicrob Agents Chemother,2005,49(11):4733.
  • 7Pai H,Kim J W,Kim J,et al.Carbapenem resistance mechanism in pseudomonas aeruginosa clinical isolates[J].Antimicrob Agents Chemother,2001,45(2):480.
  • 8钟国权,郑淑姝,梁金水,周秀琴.产AmpC酶革兰阴性杆菌的分布与耐药性研究[J].中华医院感染学杂志,2005,15(1):100-102. 被引量:12

二级参考文献10

共引文献11

同被引文献15

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部